On April 11, 2024, Merck & Co., Inc announced that it has received a shareholder proposal from National Legal and Policy Center requesting the Company Board to provide a report, published on the Company website and updated at reasonable intervals omitting proprietary information and at reasonable cost that specifies the Company?s policy in response to requests, whether from agencies of the United States Government or from state governments, to aid censorship. In addition, the Company urged the shareholders to vote against the proposal at its annual general meeting of shareholders scheduled to be held on May 28, 2024.
Market Closed -
Other stock markets
|
Pre-market 07:59:32 | |||
131.7 USD | +2.39% | 131.9 | +0.16% |
05-15 | Merck to present new oncology data | CF |
05-14 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.83% | 334B | |
+35.01% | 709B | |
+28.41% | 595B | |
-2.60% | 367B | |
+5.69% | 289B | |
+14.77% | 239B | |
+9.47% | 211B | |
-3.76% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Co Receives a Shareholder Proposal from National Legal and Policy Center